Idaho Capitol Watch
SB 1189: IMMUNIZATIONS – Adds to existing law to establish provisions regarding limitation of distribution and waiver of immunity for certain human gene therapy products.
Adds new Section 39-4806 to Idaho Code prohibiting distribution, sale, or administration of human gene therapy products for infectious diseases unless manufacturers waive immunity from design defect lawsuits, including under federal vaccine law (42 U.S.C. 300aa-1). Defines gene therapy products broadly. Effective July 1, 2025 via emergency clause.
Status
Reported Printed (March 25, 2025) · Originated in the Idaho Senate · Introduced March 24, 2025
Sponsors
- JUDICIARY AND RULES COMMITTEE
Committees
- JR for Printing
Bill history
- March 24, 2025 — Senate: Introduced; read first time; referred to JR for Printing
- March 25, 2025 — Senate: Reported Printed; referred to Health & Welfare
If this preview does not update automatically, use the full page link.